GCI Virtual Summit Thought Leader – Guillermo Velasco, Complutense University of Madrid

GCI Summit - Guillermo Velasco - Complutense University of Madrid - GCI Virtual Summit - Global Cannabis Intelligence

GCI Virtual Summit Thought Leader – Guillermo Velasco, Complutense University of Madrid

Guillermo participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.

Check out his bio below:

Guillermo Velasco studied Biology (1988-1993) and completed his doctoral thesis at the Department of Biochemistry and Molecular Biology I of the Faculty of Chemical Sciences of the Complutense University under the direction of Dr. Manuel Guzmán (1994-1997). Later he made a post-doctoral stay supported with an EMBO long-term scholarship in the laboratory of Dr. Philip Cohen (1998-1999) at the University of Dundee, Scotland, where he became familiar with the study of cell signaling mechanisms. In 1999, he rejoined the Department of Biochemistry and Molecular Biology I as Assistant Professor. Since February 2008, Guillermo Velasco has been Associate Professor at the Department of Biochemistry and Molecular Biology of the Complutense University of Madrid.

Since 2001 Guillermo Velasco has developed a line of research focused on the study of the molecular mechanisms underlying the antitumor action of cannabinoids, as well as in the optimization of the use of these agents as anticancer agents.

The results of the studies developed by the group coordinated by Guillermo Velasco have led to more than 90 articles and reviews published in internationally recognized journals in the fields of Molecular Biology and Biomedical research, to three patent applications. Likewise, these observations have contributed to set the bases for the development of three clinical trials, two of them based on the use of cannabinoids in patients with Glioblastoma.

Guillermo Velasco has been the principal investigator of numerous research projects financed by national and international agencies, as well as from private foundations. Likewise, he is part of the editorial committee of several scientific journals (including Medical Cannabis & Cannabinoids). He has been invited to talk to numerous conferences in relation to the possible use of cannabinoids for therapeutic purposes and is a member of the board of directors of the Spanish Observatory of Medical Cannabis.

If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.

You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.